Actively Recruiting
HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
Led by Zi-Xiao Li · Updated on 2025-07-02
70
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
CONDITIONS
Official Title
HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ischemic stroke with the first incident occurring within 2 weeks
- Montreal Cognitive Assessment (MoCA) score less than 26
You will not qualify if you...
- History of cerebral hemorrhage or subarachnoid hemorrhage
- Pre-existing history of epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Tiantan hospital
Beijing, China, 100070
Actively Recruiting
Research Team
W
Weili Jia, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here